Literature DB >> 18284185

Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regions.

Marilena Manea1, Adrián Kalászi, Gábor Mezo, Kata Horváti, Andrea Bodor, Anikó Horváth, Odön Farkas, András Perczel, Michael Przybylski, Ferenc Hudecz.   

Abstract

Here we report on the synthesis, antibody binding, and QSAR studies of a series of linear and cyclic peptides containing a beta-amyloid plaque-specific epitope (Abeta(4-10); FRHDSGY). In these constructs, two or three alpha- l-Ala, alpha- d-Ala, or beta-Ala residues were introduced at both N- and C-termini of the epitope as non-native flanking sequences. Cyclization of the linear Abeta(4-10) epitope peptide resulted in reduced antibody binding. However, the antibody binding could be fully compensated by insertion of alanine flanks into the corresponding cyclic peptides. These results indicate that the modification of a beta-amyloid plaque-specific epitope by combination of cyclization and flanking sequences could generate highly antigenic peptides compared to the native sequence. A novel 3D QSAR method, which explicitly handles conformational flexibility, was developed for the case of such molecular libraries. This method led to the prediction of the binding conformation for the common FRHDSGY sequence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284185     DOI: 10.1021/jm070196e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Separation of β-Amyloid Tryptic Peptide Species with Isomerized and Racemized l-Aspartic Residues with Ion Mobility in Structures for Lossless Ion Manipulations.

Authors:  Gabe Nagy; Komal Kedia; Isaac K Attah; Sandilya V B Garimella; Yehia M Ibrahim; Vladislav A Petyuk; Richard D Smith
Journal:  Anal Chem       Date:  2019-03-12       Impact factor: 6.986

2.  Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.

Authors:  Madalina Maftei; Franka Thurm; Vera Maria Leirer; Christine A F von Arnim; Thomas Elbert; Michael Przybylski; Iris-Tatjana Kolassa; Marilena Manea
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.